This blog is based off of the AAST 2019 Annual Meeting Session "Obstructive Sleep Apnea and Stroke: Evidence, Mechanisms, and Treatment Strategies." For more information on this session and other session recordings click here. Ischemic stroke (or acute stroke) is the second leading cause of long-term disability. Many who suffer from ischemic stroke also have obstructive sleep apnea (OSA). Currently, ischemic stroke treatment therapies have a very limited therapeutic window and aren’t widely applicable to most patients. The treatment of OSA in patients with acute ischemic stroke is now being looked to as a novel, therapeutic approach to preventing stroke.
As a sleep technologist, you likely know COVID-19 has disrupted many people's lives, and can cause a dilemma for individuals struggling with sleep apnea. In the COVID-19 era, sleep is more important than ever for your patient’s physical and mental health and their immune systems. Here, and through his YouTube channel, Dr. Bob Ledda, M.D., a health and wellness physician at Community Health & Wellness Center, shows there is scientific evidence pointing to the association between metabolic diseases and poor sleep. Dr, Bob, who is a partner at Cenegenics® Alaska, talks about the physiology and long-standing medical consequences of sleep apnea, what the various treatment options are, and what supplements he suggests that scientific studies have shown to improve sleep.
Access tools and resources related to earning your CCSH credential and sign up to receive updates from AAST.
Two common sleep/pulmonary diseases are obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD). These two conditions can occur simultaneously creating a condition known as Overlap Syndrome, which creates two fold the uncomfortable disordered breathing conditions, according to the American Sleep Apnea Association. It results in long-term chronic health issues that go beyond your lungs, like heart disease and diabetes, and their linked myriad complications.